Showing 1 - 20 results of 237 for search '"pharmacodynamics"', query time: 0.05s Refine Results
  1. 1
  2. 2
  3. 3

    Pharmacodynamics of interspecies interactions in polymicrobial infections by C. Herzberg, J. G. C. van Hasselt

    Published 2025-01-01
    “…Abstract The pharmacodynamic response of bacterial pathogens to antibiotics can be influenced by interactions with other bacterial species in polymicrobial infections (PMIs). …”
    Get full text
    Article
  4. 4

    Population pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients by Peng Zou, Akhilesh Atluri, Peter Chang, Michael Goedecke, Tarek A. Leil

    Published 2025-01-01
    “…Population pharmacokinetic (PK) and pharmacodynamic (PD) analyses were performed to characterize the PK and PK–PD relationships of edoxaban in pediatric patients to identify the covariates that may contribute to inter‐subject variability in PK and PD of edoxaban in pediatric patients, and to compare the PK and PD data between pediatric and adult patients. …”
    Get full text
    Article
  5. 5

    Nutrient conditions affect antimicrobial pharmacodynamics in Pseudomonas aeruginosa by Maik Kok, Thomas Hankemeier, J. G. Coen van Hasselt

    Published 2025-01-01
    “…Using pharmacokinetic-pharmacodynamic simulations, we illustrate that the magnitude of the nutrient-driven pharmacodynamic changes impact treatment for clinical dosing strategies of tobramycin. …”
    Get full text
    Article
  6. 6
  7. 7

    Cimetidine Pharmacodynamics and Pharmacokinetics in Healthy Subjects: A Comparison of Tablets and Suspension by ABR Thomson, P Kirdeikis, L Zuk, RE Samuels, P Zarevics

    Published 1994-01-01
    “…These pharmacokinetic variations between cimetidine suspension and tablets may have partially explained the pharmacodynamic differences of the lower area under the pH time curve (0 to 6 h). …”
    Get full text
    Article
  8. 8
  9. 9
  10. 10

    In vivo pharmacokinetic and pharmacodynamic study and cutoff of florfenicol against Riemerella anatipestifer in ducks by Hui-Lin Zhang, Fa-Lei Li, Hui-Yang Chen, Ding-Mei Qin, Shu-Jun Sun, Meng-Meng Zhang, Huan-Zhong Ding, Yong Liu

    Published 2025-01-01
    “…This study investigated the pharmacokinetic/pharmacodynamic (PK/PD) integration of florfenicol (FF) against R. anatipestifer by establishing a systemic infection model in ducks. …”
    Get full text
    Article
  11. 11
  12. 12
  13. 13

    Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease by O. A. Storonova, A. S. Trukhmanov

    Published 2015-12-01
    “…To present literature data on clinical presentation, pharmacodynamic and economic efficiency of standard dozes of proton pump inhibitors (PPI) for gastroesophageal reflux disease (GERD).Summary. …”
    Get full text
    Article
  14. 14

    Development, Characterization, and Pharmacodynamic Evaluation of Hydrochlorothiazide Loaded Self-Nanoemulsifying Drug Delivery Systems by Pankajkumar S. Yadav, Ekta Yadav, Amita Verma, Saima Amin

    Published 2014-01-01
    “…Optimized SNEDDS formulation was composed of Capmul MCM (19.17% w/w), Tween 80 (57.5% w/w), Transcutol P (12.7% w/w), and HCT (4.17% w/w). In vivo pharmacodynamic evaluation in Wistar rats showed considerable increase in pharmacological effect of HCT by SNEDDS formulation as compared with plain HCT.…”
    Get full text
    Article
  15. 15

    Pharmacodynamic Profiling of Antimicrobials against Gram-negative Respiratory Isolates from Canadian Hospitals by Rebecca A. Keel, George G. Zhanel, Sheryl Zelenitsky, David P. Nicolau

    Published 2011-01-01
    “…These results support that the currently recommended antimicrobial dosing regimens generally attain acceptable exposures to achieve the requisite pharmacodynamic targets against the Enterobacteriaceae species; however, they fall short of obtaining optimal bactericidal exposures against P aeruginosa.…”
    Get full text
    Article
  16. 16
  17. 17

    Pharmacodynamics of TRPV1 Agonists in a Bioassay Using Human PC-3 Cells by Daniel Alvarez-Berdugo, Marcel Jiménez, Pere Clavé, Laia Rofes

    Published 2014-01-01
    “…In addition, PC-3 cell bioassays proved useful in the study of TRPV1 pharmacodynamics.…”
    Get full text
    Article
  18. 18
  19. 19
  20. 20

    A prospective study to evaluate high dose daptomycin pharmacokinetics and pharmacodynamics in spp. infective endocarditis by Simona De Gregori, Annalisa De Silvestri, Mara Capone, Vincenzina Monzillo, Paola Giordani, Raffaele Bruno, Elena Seminari

    Published 2025-01-01
    “…Background: Daptomycin pharmacokinetics and pharmacodynamics data relative to higher doses in patients are necessary for clinical practice. …”
    Get full text
    Article